Neurologic disorders associated with inflammatory bowel disease

European Journal of Neurology

Volumn 18, Issue 1, 2011, Pages 138-143

  Benavente, L ^a   Moris G ^b  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b HOSPITAL SAN AGUSTÍN   (Spain)

Author keywords

Extraintestinal manifestations; Inflammatory bowel disease; Multiple sclerosis; Neuropathy; Stroke

Indexed keywords

INFLIXIMAB; MESALAZINE; SALAZOSULFAPYRIDINE; STEROID;

ADOLESCENT; ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN ISCHEMIA; CEREBRAL SINUS THROMBOSIS; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DEMYELINATING DISEASE; DISEASE ASSOCIATION; EPILEPSY; FEMALE; HAND PARESTHESIA; HUMAN; IATROGENIC DISEASE; MALE; MEDICAL RECORD REVIEW; MULTIPLE SCLEROSIS; MYELITIS; MYOCLONUS; NEUROLOGIC DISEASE; OPTIC NERVE DISEASE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SPINAL CORD DISEASE; ULCERATIVE COLITIS; VITAMIN DEFICIENCY;

ADOLESCENT; ADULT; AGED; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN;

EID: 78650145671     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.03095.x     Document Type: Article

References (42)

1. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet 2007; 369: 1627-1640.
2. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007; 369: 1641-1657.
3. Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 2001; 96: 1116-1122.
4. Danese S, Semeraro S, Papa A, et al. Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol 2005; 11: 7227-7236.
5. Ephgrave K. Extra-intestinal manifestations of Crohn's disease. Surg Clin North Am 2007; 87: 673-680.
6. Elsehety A, Bertorini TE. Neurologic and neuropsychiatric complications of Crohn's disease. South Med J 1997; 90: 606-610.
7. Lossos A, River Y, Eliakim A, Steiner I. Neurologic aspects of inflammatory bowel disease. Neurology 1995; 45: 416-421.
8. Scheid R, Teich N. Neurologic manifestations of ulcerative colitis. Eur J Neurol 2007; 14: 483-493.
9. Wills AJ, Penigran Tengah DS, Holes GK. The neurology of enteric disease. J Neurol Neurosurg Psychiatry 2006; 77: 805-810.
10. Oliveira GR, Teles BC, Brasil EF, et al. Peripheral neuropathy and neurological disorders in an unselected Brazilian population-based cohort of IBD patients. Inflamm Bowel Dis 2008; 14: 389-395.
11. Morís G, Milla A, Ribacoba R, González C. Acute deafness as an extraintestinal manifestation of ulcerative colitis. Eur J Intern Med 2005; 16: 440-442.
12. Rodríguez S, Calleja S, Morís G. Cluster-like headache heralding cerebral venous thrombosis. Cephalalgia 2008; 28: 906-907.
13. Bernstein CN, Blanchard JF, Rawsthorne P, Wajda A. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol 1999; 149: 916-924.
14. Lapidus A. Crohn's disease in Stockholm County during 1990-2001: an epidemiological update. World J Gastroenterol 2006; 12: 75-81.
15. Saro Gismera C, Riestra Menéndez S, Milla Crespo A, et al. Incidence and prevalence of inflammatory bowel disease. Asturian study in 5 areas (EIICEA). Spain. An Med Interna 2003; 20: 3-9.
16. Saro Gismera C, Riestra Menéndez S, Sánchez Fernández R, et al. Epidemiology in inflammatory bowel disease in five areas of Asturias. Spain. An Med Interna 2003; 20: 232-238.
17. de Lau LML, de Vries JM, van der Woude CJ, et al. Acute CNS white matter lesions in patients with inflammatory bowel disease. Inflamm Bowel Dis 2009; 15: 576-580.
18. Gondim FAA, Brannagan TH, Sander H, Chin RL, Latov N. Peripheral neuropathy in patients with inflammatory bowel disease. Brain 2005; 128: 867-879.
19. Miechsler W, Reinisch W, Valic E. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 2004; 53: 542-548.
20. Papa A, Danesee S, Grillo A, Gasbarrini G, Gasbarrini A. Review article: inherited thrombophilia in inflammatory bowel disease. Am J Gastroenterol 2003; 98: 1247-1251.
21. Rang EH, Brooke BN, Hermon-Taylor J. Association of ulcerative colitis with multiple sclerosis. Lancet 1982; 2: 555.
22. Sharma P, Makharia GK, Ahuja V, Dwivedi SN, Deepak KK. Autonomic dysfunctions in patients with inflammatory bowel disease in clinical remission. Dig Dis Sci 2009; 54: 853-861.
23. Weinstock LB, Bosworth BP, Scherl EJ, et al. Crohn's disease is associated with restless legs syndrome. Inflamm Bowel Dis 2010; 16: 275-279.
24. Geissler A, Andus T, Roth M, et al. Focal white-matter lesions in brain of patients with inflammatory bowel disease. Lancet 1995; 345: 897-898.
25. Gupta G, Gelfand JM, Lewis JD. Increase risk for demyelinating diseases in patients with bowel disease. Gastroenterology 2005; 129: 819-826.
26. Sadovnick AD, Paty DW, Yannakoulias G. Concurrence of multiple sclerosis and inflammatory bowel disease. N Eng J Med 1989; 321: 762-763.
27. Nielsen NM, Frisch M, Rostgaard K, et al. Autoimmune diseases in patients with multiple sclerosis and their first-degree relatives: a nationwide cohort study in Denmark. Mult Scler 2008; 14: 823-829.
28. Goverman J. Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 2009; 9: 393-407.
29. Lossos A, Argov Z, Ackerman Z, Abramsky O. Peripheral neuropathy and folate deficiency at the first sign of Crohn's disease. J Clin Gastroenterol 1991; 13: 442-444.
30. Boyce EG, Cookson ET, Bond WS. Persistent metronidazole-induced peripheral neuropathy. Ann Pharmacother 1990; 24: 19-21.
31. de la Fuente-Fernandez R, Rubio-Nazabal E, de la Iglesia-Martinez F. Guillain-Barre syndrome as an extraintestinal manifestation of Crohn's disease. Postgrad Med J 1995; 71: 437-438.
32. Bargen JA, Nelson WB. Extensive arterial and venous thrombosis complicating ulcerative colitis. Arch Intern Med 1936; 58: 17-31.
33. Sibai M, El Moutawakil B, Chourkani N, Bourezgui M, Rafai MA, Slassi I. Neurological manifestations of chronic inflammatory bowel disease. Rev Neurol 2008; 164: 859-865.
34. Bermejo PE, Burgos A. Neurological complications of inflammatory bowel disease. Med Clin 2008; 130: 666-675.
35. Markowitz RL, Ment LR, Gruboski JD. Cerebral thromboembolic disease in paediatric and adult inflammatory bowel disease: case report and review of the literature. J Pediatr Gastroenterol Nutr 1989; 8: 413-420.
36. Danese S, Papa A, Saibeni S, Repici A, Malesci A, Vecchi M. Inflammation and coagulation in inflammatory bowel disease: the clot thickens. Am J Gastroenterol 2007; 102: 174-186.
37. Guedon C, Le Cam-Duchez V, Lalaude O, Ménard JF, Lerebours E, Borg JY. Prothrombotic inherited abnormalities other than factor V Leiden mutation do not play a role in venous thrombosis in inflammatory bowel disease. Am J Gastroenterol 2001; 96: 1448-1454.
38. Mahmud N, Mohillo A, McPartlin J, et al. Increased prevalence of methylene tetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications. Gut 1999; 45: 389-394.
39. Aichbichler BW, Petritsch W, Reicht GA, et al. Anticardiolipin antibodies in patients with inflammatory bowel disease. Dig Dis Sci 1999; 44: 852-856.
40. Wang JY, Terdiman JP, Vittinghoff E, Minichiello T, Varma MG. Hospitalized ulcerative colitis patients have an elevated risk of thromboembolic events. World J Gastroenterol 2009; 15: 927-935.
41. Vrij AA, Rijken J, van Wersch JW, Stockbrügger RW. Differential behaviour of coagulation factor XII in patients with inflammatory bowel disease and in patients with giant cell arteritis. Haemostasis 1999; 29: 326-335.
42. Ha C, Magowan S, Accortt NA, Chen J, Stone CD. Risk of arterial thrombotic events in inflammatory bowel disease. Am J Gastroenterol 2009; 104: 1445-1451.